Fildena, which contains sildenafil citrate, is commonly prescribed for erectile dysfunction. However, it is contraindicated in certain cardiac patients due to its cardiovascular effects. Sildenafil works by inhibiting phosphodiesterase type 5 (PDE5), resulting in vasodilation and lowered blood pressure. This can pose serious risks for patients with heart conditions.
FILDENA is strictly contraindicated in patients who are using nitrate medications (e.g., nitroglycerin, isosorbide dinitrate) for chest pain or heart disease. The combination can lead to a dangerous and potentially life-threatening drop in blood pressure. Similarly, patients on guanylate cyclase stimulators like riociguat should avoid Fildena.
Caution is also advised in individuals with severe cardiovascular disorders, such as recent myocardial infarction (heart attack), unstable angina, severe hypotension, uncontrolled hypertension, or significant arrhythmias. These conditions can be exacerbated by the hemodynamic changes caused by sildenafil.
Furthermore, patients with congestive heart failure or cardiomyopathy should use Fildena only under strict medical supervision, as sexual activity itself may increase cardiac workload and precipitate adverse events.
In summary, Fildena should be avoided in cardiac patients taking nitrates or those with unstable cardiovascular conditions. A thorough cardiac evaluation is essential before initiating treatment with sildenafil in any heart disease patient.
Add your comment